CATNAP
Conditions: Clinical Diagnosis of Narcolepsy I or II
Type of Research: Observational
Principal Investigator: Michael Strunc MD
Study Specifications: Narcolepsy is a lifelong, debilitating neurological disorder, clinically characterized by a pentad of symptoms including excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic hallucinations, and disrupted nighttime sleep. There is little information in the literature regarding pediatric narcolepsy. CATNAP is an observational studying aiming to study the natural history, practices, and outcomes of pediatric narcolepsy.
Email: CRU@chkd.org
Phone: (757) 668-5416
TAK-861-2001
Conditions: Narcolepsy with Cataplexy (Narcolepsy Type 1)
Type of Research: Prospective
Principal Investigator: Michael Strunc, MD
Study Specifications:Narcolepsy is a rare chronic sleep disorder that alters sleep-state stability. The main symptom is the sudden need to sleep during the day’s normal period periods of alertness. Disturbed nighttime sleep and the inability to continue nocturnal sleep is also a symptom. This study will evaluate the safety, efficacy and tolerability of TAK-861 for treatment of Narcolepsy with Cataplexy in adult subjects ages 18-70.
Email: CRU@chkd.org
Phone: (757) 668-5416
TAK-861-2002
Conditions: Narcolepsy without Cataplexy (Narcolepsy Type 2)
Type of Research: Prospective
Principal Investigator: Michael Strunc, MD
Study Specifications:This study will evaluate the safety, efficacy and tolerability of TAK-861 for treatment of Narcolepsy without Cataplexy in adult subjects ages 18-70.
Email: CRU@chkd.org
Phone: (757) 668-5416
TAK-861-2003
Conditions: Central Hypersomnia
Type of Research: Prospective
Principal Investigator: Michael Strunc, MD
Study Specifications:This study will evaluate the long-term safety and tolerability of TAK-861, along with PK and pharmacodynamic evaluations in participants receiving oral doses.
Email: CRU@chkd.org
Phone: (757) 668-5416
